Boothbay Fund Management’s Sierra Oncology, Inc. Common Stock SRRA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q2 | – | Sell |
-28,513
| Closed | -$914K | – | 2526 |
|
|
2022
Q1 | $914K | Sell |
28,513
-38,773
| -58% | -$1.24M | 0.02% | 763 |
|
|
2021
Q4 | $1.46M | Buy |
67,286
+9,514
| +16% | +$207K | 0.03% | 504 |
|
|
2021
Q3 | $1.27M | Sell |
57,772
-6,930
| -11% | -$152K | 0.04% | 519 |
|
|
2021
Q2 | $1.26M | Buy |
64,702
+11,335
| +21% | +$221K | 0.04% | 504 |
|
|
2021
Q1 | $920K | Buy |
53,367
+14,801
| +38% | +$255K | 0.03% | 516 |
|
|
2020
Q4 | $618K | Buy |
38,566
+565
| +1% | +$9.05K | 0.02% | 551 |
|
|
2020
Q3 | $405K | Buy |
+38,001
| New | +$405K | 0.02% | 613 |
|
|
2019
Q4 | – | Sell |
-3,034
| Closed | -$47K | – | 973 |
|
|
2019
Q3 | $47K | Hold |
3,034
| – | – | ﹤0.01% | 629 |
|
|
2019
Q2 | $68K | Hold |
3,034
| – | – | 0.01% | 579 |
|
|
2019
Q1 | $208K | Hold |
3,034
| – | – | 0.02% | 504 |
|
|
2018
Q4 | $160K | Buy |
3,034
+278
| +10% | +$14.7K | 0.02% | 432 |
|
|
2018
Q3 | $187K | Hold |
2,756
| – | – | 0.02% | 540 |
|
|
2018
Q2 | $326K | Sell |
2,756
-711
| -21% | -$84.1K | 0.03% | 339 |
|
|
2018
Q1 | $287K | Buy |
+3,467
| New | +$287K | 0.03% | 385 |
|